vs
AMREP CORP.（AXR）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
AMREP CORP.的季度营收约是礼来的1.2倍（$14.6M vs $12.5M），AMREP CORP.净利率更高（21.6% vs -1398.3%，领先1419.9%），礼来同比增速更快（434.0% vs 93.8%），AMREP CORP.自由现金流更多（$5.4M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
AXR vs RNA — 直观对比
营收规模更大
AXR
是对方的1.2倍
$12.5M
营收增速更快
RNA
高出340.2%
93.8%
净利率更高
AXR
高出1419.9%
-1398.3%
自由现金流更多
AXR
多$162.3M
$-156.9M
两年增速更快
RNA
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $12.5M |
| 净利润 | $3.1M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | 20.6% | -1513.5% |
| 净利率 | 21.6% | -1398.3% |
| 营收同比 | 93.8% | 434.0% |
| 净利润同比 | 338.9% | -117.0% |
| 每股收益（稀释后） | $0.58 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRRNA
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | — | ||
| Q3 25 | $17.9M | $12.5M | ||
| Q2 25 | $11.2M | $3.8M | ||
| Q1 25 | $7.5M | $1.6M | ||
| Q4 24 | $11.9M | $3.0M | ||
| Q3 24 | $19.1M | $2.3M | ||
| Q2 24 | $19.5M | $2.0M |
净利润AXRRNA
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | — | ||
| Q3 25 | $4.7M | $-174.4M | ||
| Q2 25 | $3.9M | $-157.3M | ||
| Q1 25 | $717.0K | $-115.8M | ||
| Q4 24 | $4.0M | $-102.3M | ||
| Q3 24 | $4.1M | $-80.4M | ||
| Q2 24 | $4.1M | $-70.8M |
营业利润率AXRRNA
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | — | ||
| Q3 25 | 34.4% | -1513.5% | ||
| Q2 25 | 31.7% | -4448.7% | ||
| Q1 25 | 5.7% | -8360.9% | ||
| Q4 24 | 26.4% | -4069.6% | ||
| Q3 24 | 26.1% | -4200.9% | ||
| Q2 24 | 23.9% | -4040.4% |
净利率AXRRNA
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 26.3% | -1398.3% | ||
| Q2 25 | 34.8% | -4089.3% | ||
| Q1 25 | 9.5% | -7360.0% | ||
| Q4 24 | 33.9% | -3439.5% | ||
| Q3 24 | 21.3% | -3441.7% | ||
| Q2 24 | 21.2% | -3461.8% |
每股收益（稀释后）AXRRNA
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.87 | $-1.27 | ||
| Q2 25 | $0.73 | $-1.21 | ||
| Q1 25 | $0.13 | $-0.90 | ||
| Q4 24 | $0.75 | $-0.80 | ||
| Q3 24 | $0.76 | $-0.65 | ||
| Q2 24 | $0.77 | $-0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $350.2M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | $1.9B |
| 总资产 | $143.9M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRRNA
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | — | ||
| Q3 25 | $48.9M | $350.2M | ||
| Q2 25 | $39.5M | $243.9M | ||
| Q1 25 | $36.9M | $254.2M | ||
| Q4 24 | $40.1M | $219.9M | ||
| Q3 24 | $40.4M | $370.2M | ||
| Q2 24 | $29.7M | $575.8M |
总债务AXRRNA
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
股东权益AXRRNA
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | — | ||
| Q3 25 | $134.7M | $1.9B | ||
| Q2 25 | $130.0M | $1.2B | ||
| Q1 25 | $126.0M | $1.3B | ||
| Q4 24 | $125.1M | $1.4B | ||
| Q3 24 | $122.2M | $1.5B | ||
| Q2 24 | $118.0M | $1.2B |
总资产AXRRNA
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | — | ||
| Q3 25 | $140.7M | $2.1B | ||
| Q2 25 | $133.8M | $1.4B | ||
| Q1 25 | $128.9M | $1.5B | ||
| Q4 24 | $129.1M | $1.6B | ||
| Q3 24 | $127.0M | $1.6B | ||
| Q2 24 | $122.8M | $1.3B |
负债/权益比AXRRNA
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $-156.9M |
| 自由现金流率自由现金流/营收 | 37.0% | -1257.6% |
| 资本支出强度资本支出/营收 | 0.1% | 5.7% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流AXRRNA
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | $-156.2M | ||
| Q2 25 | $10.2M | $-199.7M | ||
| Q1 25 | $-3.2M | $-124.8M | ||
| Q4 24 | $-182.0K | $-99.9M | ||
| Q3 24 | $10.7M | $-65.6M | ||
| Q2 24 | $10.7M | $-65.0M |
自由现金流AXRRNA
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | $-156.9M | ||
| Q2 25 | $9.7M | $-203.0M | ||
| Q1 25 | $-3.3M | $-128.6M | ||
| Q4 24 | $-268.0K | $-103.8M | ||
| Q3 24 | $10.7M | $-67.3M | ||
| Q2 24 | $10.3M | $-65.5M |
自由现金流率AXRRNA
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | -1257.6% | ||
| Q2 25 | 86.4% | -5277.1% | ||
| Q1 25 | -43.4% | -8174.3% | ||
| Q4 24 | -2.3% | -3491.0% | ||
| Q3 24 | 55.8% | -2881.8% | ||
| Q2 24 | 52.5% | -3204.6% |
资本支出强度AXRRNA
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.1% | 5.7% | ||
| Q2 25 | 5.2% | 86.9% | ||
| Q1 25 | 0.3% | 238.6% | ||
| Q4 24 | 0.7% | 131.7% | ||
| Q3 24 | 0.2% | 72.9% | ||
| Q2 24 | 2.3% | 26.0% |
现金转化率AXRRNA
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
